Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T19:53:00.120Z.
Calculation as of: 2026-10-06T19:53:00.120Z.
Quote observation: 2026-10-06T19:50:06.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5a8aae8e93f82a899e51ff603ce0499f2ee8a4244ac8b174beef8711f00adb15
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Spectral AI, Inc.
Market Cap
$52.99M
Free Cash Flow Yield
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD |
|---|---|---|
| Spectral AI, Inc. (MDAI) | $52.99M | N/A |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $53.12M | N/A |
| Zhengye Biotechnology Holding Limited (ZYBT)vs › | $52.60M | N/A |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $53.71M | N/A |
| eXoZymes, Inc. (EXOZ)vs › | $51.98M | N/A |
| ImageneBio Inc (IMA)vs › | $51.43M | N/A |
| Aldeyra The (ALDX)vs › | $54.46M | N/A |
| Envoy Medical, Inc. (COCH)vs › | $50.99M | N/A |
| Tenax Therapeutics, Inc. (TENX)vs › | $50.66M | N/A |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $50.00M | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
